Navina Technologies Ltd.

Navina Technologies Ltd. , based in Israel, specializes in advanced AI solutions for healthcare, empowering providers to improve patient care through enhanced data integration and actionable clinical insights. Founded in 2018, Navina Technologies Ltd. operates from New York, US, and focuses on developing clinician-first AI platforms that enhance healthcare delivery.

The company has secured a total of USD 55. 00 mn from four funding deals. Its latest funding round, a Series C, occurred on March 25, 2025, led by Goldman Sachs Merchant Banking Division with participation from ALIVE, Grove Ventures, and Vertex Ventures Israel. The founders are Drew Hume, Ronen Lavi, and Shay Perera, with Ronen Lavi currently serving as CEO.

Navina's core product offerings revolve around its clinician-first AI platform, designed to enhance value-based care through improved data integration and clinical insights. The platform consolidates complex and fragmented patient data from various unstructured sources into a single, actionable summary that can be accessed at the point of care. Key functionalities include efficient chart reviews that allow clinicians to examine patient records in under two minutes, and AI-powered Hierarchical Condition Category (HCC) recommendations that help identify and document chronic conditions. This significantly improves risk adjustment factor (RAF) accuracy and streamlines quality management by uncovering clinical gaps and managing care discrepancies without extensive data mining.

Navina primarily serves healthcare providers, Accountable Care Organizations (ACOs), Managed Service Organizations (MSOs), and health plans across multiple geographic markets, including the United States and select international regions. Navina's revenue model is primarily structured around subscription services for its AI-driven platform, targeting B2B transactions with healthcare providers and organizations. Clients typically engage in annual contracts that grant them access to the platform's suite of tools, including features for risk adjustment, quality management, and analytics. These subscriptions may vary based on the size of the client organization and the specific features utilized.

By implementing Navina’s platform, healthcare providers can optimize their clinical workflows and improve patient engagement, thereby enhancing their overall operational efficiency. The revenue generated from these partnerships is instrumental in facilitating ongoing product development and support, reinforcing Navina’s commitment to delivering innovative solutions in the healthcare sector. In March 2025, Navina Technologies Ltd. raised USD 55.

00 mn in Series C funding, led by Goldman Sachs Asset Management, to expand its market reach across the U. S. healthcare market and enhance its proprietary AI technology. The funding will support the development of new products aimed at further improving clinical workflows and patient care.

The company is strategically targeting expansion into additional geographic regions to enhance its footprint in the healthcare sector.